Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Reinisch

Showing results (51-60 of 352) with videos related to

Pageof 36
Sort By:
Journal of Clinical Pharmacology|January 31, 2018
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard SystemAlexander Eser, Christian Primas, Sieglinde Reinisch, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysisParul Tandon, Navneet Natt, Gurpreet Malhi, et al.
The American Journal of Gastroenterology|December 23, 2008
Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnosticsWolfgang Tillinger, Ruth Jilch, Bernd Jilma, et al.
AJR. American Journal of Roentgenology|November 24, 2005
Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's diseaseJohannes Sailer, Philipp Peloschek, Ewald Schober, et al.
Inflammatory Bowel Diseases|April 28, 2023
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity IndexEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|June 16, 2025
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Wiener Klinische Wochenschrift|December 1, 2022
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early RespondersEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|April 2, 2022
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical TrialsManasi Agrawal, Francesca Petralia, Adam Tepler, et al.
Inflammatory Bowel Diseases|September 25, 2025
Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative ColitisEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Pageof 36

Showing results (51-60 of 352) with videos related to

Sort By:
Pageof 36
Journal of Clinical Pharmacology|January 31, 2018
Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard SystemAlexander Eser, Christian Primas, Sieglinde Reinisch, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2023
Clinical remission in paired phase two and three studies in inflammatory bowel disease: a systematic review with meta-analysisParul Tandon, Navneet Natt, Gurpreet Malhi, et al.
The American Journal of Gastroenterology|December 23, 2008
Expression of the high-affinity IgG receptor FcRI (CD64) in patients with inflammatory bowel disease: a new biomarker for gastroenterologic diagnosticsWolfgang Tillinger, Ruth Jilch, Bernd Jilma, et al.
AJR. American Journal of Roentgenology|November 24, 2005
Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's diseaseJohannes Sailer, Philipp Peloschek, Ewald Schober, et al.
Inflammatory Bowel Diseases|April 28, 2023
Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity IndexEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|June 16, 2025
Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn's DiseaseEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Wiener Klinische Wochenschrift|December 1, 2022
Tofacitinib in the treatment of ulcerative colitis : A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)Maximilian Kutschera, Gottfried Novacek, Walter Reinisch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early RespondersEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Inflammatory Bowel Diseases|April 2, 2022
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical TrialsManasi Agrawal, Francesca Petralia, Adam Tepler, et al.
Inflammatory Bowel Diseases|September 25, 2025
Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative ColitisEmily C L Wong, Parambir S Dulai, John K Marshall, et al.
Pageof 36